Clinical Trials
68 trialsGenetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
Mayo Clinic
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
OHSU Knight Cancer Institute
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
City of Hope Medical Center
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
City of Hope Medical Center
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Mayo Clinic
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mayo Clinic
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
M.D. Anderson Cancer Center
NEOEPICURE
Institut Cancerologie de l'Ouest
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
M.D. Anderson Cancer Center
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
SPAM
Centre Oscar Lambret
NoCUT-BC
Ohio State University Comprehensive Cancer Center
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
Memorial Sloan Kettering Cancer Center
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Dana-Farber Cancer Institute
AVATAR
Institut Curie
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
Dana-Farber Cancer Institute
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
University of Washington
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Mayo Clinic
NEO-ELASTO
Institut Curie
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer
City of Hope Medical Center
Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
Lund University Hospital
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
UNC Lineberger Comprehensive Cancer Center
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
University of Washington
ONAC
Second Affiliated Hospital, School of Medicine, Zhejiang University
AI Model for Classifying Breast Cancer From Histopathology Images
Bangladesh University of Engineering and Technology
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer
Wake Forest University Health Sciences
Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)
Institut Curie
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
University of Southern California
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
University of Nebraska
Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
University of Michigan Rogel Cancer Center
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
Assiut University
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Karolinska University Hospital
SAFIR-TOR
UNICANCER
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
Fudan University
Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer
Indiana University
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Inova Health Care Services
ULTIMATE
UNICANCER
MRI to Detect Breast Tumors in Women
Abramson Cancer Center at Penn Medicine
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
Abramson Cancer Center at Penn Medicine
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
Northwestern University
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Barbara Ann Karmanos Cancer Institute
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
Columbia University
AGATA
SOLTI Breast Cancer Research Group
Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study
Samsung Medical Center
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NOMAT01
Gustave Roussy, Cancer Campus, Grand Paris